News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Ferro Corporation Reports 2007 Second-Quarter Results
August 9, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CLEVELAND--(BUSINESS WIRE)--Ferro Corporation (NYSE:FOE) announced sales of $554 million for the quarter ended June 30, 2007, up 3 percent from sales of $538 million in the second quarter of 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Dyne gets early 2027 decision date for Duchenne therapy, analysts expect ‘smooth’ review
July 21, 2026
·
2 min read
·
Tristan Manalac
IPO
Axiom plans Hong Kong IPO, hoping to carve new path for US biotechs
July 21, 2026
·
3 min read
·
Gabrielle Masson
Psychedelics
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
July 20, 2026
·
3 min read
·
Heather McKenzie
IPO
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq
July 20, 2026
·
2 min read
·
Tristan Manalac
